Advanced Clinical Announces Gil Price as a Core Member of its Strategic Advisory Ecosystem

Share Article

Advanced Clinical, a leading provider of clinical research services, announces Gil Price, MD, as a core member of its strategic advisory ecosystem.

Working with Advanced Clinical in life sciences is intellectually stimulating and innovative. By teaming up, we also have the potential to impact the health and well being of thousands, perhaps millions, of patients.

Advanced Clinical, a leading provider of clinical research services, announces Gil Price, MD, as a core member of its strategic advisory ecosystem.

As a strategic advisor, Dr. Price brings more than 20 years of experience in drug safety and efficacy, with expertise in strategic and tactical management within clinical research. He is recognized for his work in medical and regulatory services for Phase III/IV clinical trials in several therapeutic areas. Currently Dr. Price is the CEO and CMO of Drug Safety Solutions (http://www.drugsafety.biz/). His clinical research management experience has contributed to Advanced Clinical’s Industry Leading R&D Performance (ILRDP) framework that seeks to make the “business of R&D” more effective and efficient for life sciences companies.

"Working with Advanced Clinical in life sciences is intellectually stimulating and innovative,” said Gil Price, Advanced Clinical Strategic Advisor. “By teaming up, we also have the potential to impact the health and well being of thousands, perhaps millions, of patients.”

Dr. Price received training in Big Pharma early in his career, beginning with GlaxoSmithKline (GSK). With GSK, he was placed into a variety of positions that covered all aspects of drug development, manufacturing, basic sciences and regulatory. After leaving GSK, Dr. Price went to work at Quintiles as executive vice president. He worked with clinical trials for four years and, during this time, Quintiles expanded and acquired several companies in Europe. Dr. Price was then contacted about an opportunity at MedImmune to work on multiple product launches and new invitations for old products. Additionally, he worked on medical affairs in an umbrella department that was largely responsible for all post-marketing activities involved in commercial drug development, post-marketing pharmacovigilance, post-marketing clinical studies, drug information and publication responsibilities.

Following MedImmune, Dr. Price carved out his entrepreneurial career. First, he started his own biotechnology company then later sold the company to a private group on the West Coast. Next, Dr. Price started Drug Safety Solutions, for which he is currently owner, providing services to biotechnology and pharmaceutical companies for all aspects of pharmacovigilance.

Dr. Price earned his B.S. from the University of Rio Grande (Ohio), in addition to studying political science and economics at the University of Cambridge. He earned his MD at University of Santiago (Chile). He completed a residency in internal medicine at Northeastern Ohio University College of Medicine.

About Advanced Clinical: Advanced Clinical provides consulting services, strategic sourcing (CRO), talent management, and technology solutions to the Life Sciences industry. With 15+ years of experience, Advanced Clinical is an established presence in the clinical research field, providing services specifically for Pharmaceutical, Biopharmaceutical, Biotechnology and Medical Device organizations. Advanced utilizes a value-based, “One Team” approach. To learn more, visit http://www.advancedclinical.com.

Contact:
Rosemarie Truman
rtruman(at)advancedclinical(dot)com
1200 Lakeside Drive
Bannockburn, IL 60015
Ph: 202-438-2208

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Rosemarie Truman
Visit website